PHARMING GRP SP. ADRS (PHG) — Strategic Asset Allocation Index
PHARMING GRP SP. ADRS (PHG) has a Strategic Asset Allocation Index of 3.1% as of December 2025. Strategic assets (PP&E of €- plus long-term investments of €8.65 Million) total €8.65 Million, measured against net assets of €277.10 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See PHG equity to assets ratio to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
PHARMING GRP SP. ADRS Strategic Asset Allocation Index (2021–2025)
This chart shows how PHARMING GRP SP. ADRS's Strategic Asset Allocation Index has evolved across 5 annual periods from 2021 to 2025. As of December 2025, the index stands at 3.1%, representing strategic assets of €8.65 Million against net assets of €277.10 Million EUR. For live market cap and overall valuation, see how much is PHARMING GRP SP. ADRS worth.
Annual Strategic Asset Allocation Index for PHARMING GRP SP. ADRS (2021–2025)
The table below presents the year-by-year Strategic Asset Allocation Index for PHARMING GRP SP. ADRS from 2021 to 2025, covering 5 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. See what is PHARMING GRP SP. ADRS's book value for net asset value and shareholders' equity analysis.
| Year | SAAI | Strategic Assets (EUR) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 3.1% | €8.65 Million | €- | €8.65 Million | €277.10 Million | ▲ +1.2 pp |
| 2024 | 1.9% | €4.23 Million | €- | €4.23 Million | €221.06 Million | ▼ -2.8 pp |
| 2023 | 4.8% | €10.40 Million | €- | €10.40 Million | €218.78 Million | ▼ 0.0 pp |
| 2022 | 4.8% | €9.73 Million | €- | €9.73 Million | €204.64 Million | ▲ +0.3 pp |
| 2021 | 4.5% | €8.65 Million | €- | €8.65 Million | €192.92 Million | — |